The Japanese Society for Heart Transplantation: Japanese Registry for Heart Transplantation, Aug 2022. http://www.jsht.jp/registry/japan/. Accessed 1 Feb 2023.
The Japanese Association for Thoracic Surgery: J-MACS Statistical Report. 2023. https: //www.jpats.org/society/jmacs/report.html. Accessed 1 Feb 2023.
Mehra MR, Uriel N, Naka Y, et al. Momentum 3 investigators: a fully magnetically levitated left ventricular assist device—final report. N Engl J Med. 2019;380:1618–27.
Mehra MR, Naka Y, Uriel N, et al. Momentum 3 investigators: a fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440–50.
Moazami N, Milano CA, John R, et al. HeartMate II investigators: pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg. 2013;95:500–5.
Kusne S, Mooney M, Danziger-Isakov L, et al. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant. 2017;36:1137–53.
Mutsuga M, Okumura T, Morimoto R, et al. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices. Artif Organs. 2023;47:387–95.
Article CAS PubMed Google Scholar
Cannon A, Elliott T, Ballew C, et al. Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States. Prog Transplant. 2012;22:351–9.
Slaughter MS, Pagani FD, Rogers JG, et al. HeartMate II clinical investigators: clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-39.
Kormos RL Holman W Chapter 13: Adverse events and complications of mechanical circulatory support Mechanical circulatory support: a companion to Braunwald’s heart disease editors Kormos RL Miller LW Elsevier Amsterdam 166–82 2012
Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2017;36:673–83.
Moazami N, Smedira NG, McCarthy PM, et al. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation. Ann Thorac Surg. 2001;72:1933–9.
Article CAS PubMed Google Scholar
Kitano T, Sakaguchi M, Yamagami H, et al. Mechanical thrombectomy in acute ischemic stroke patients with left ventricular assist device. J Neurol Sci. 2020;418:117142.
John R, Kamdar F, Eckman P. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg. 2011;92:1593–9.
Morgan JA, Paone G, Nemeh HW, et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2012;31:715–8.
Kushnir VM, Sharma S, Ewald GA, et al. Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endosc. 2012;75:973–9.
Imamura T, Kinugawa K, Nitta D, et al. Opening of aortic valve during exercise is key to preventing development of aortic insufficiency during ventricular assist device treatment. ASAIO J. 2015;61:514–9.
Imamura T, Kinugawa K, Nitta D, et al. Advantage of pulsatility in left ventricular reverse remodeling and aortic insufficiency prevention during left ventricular assist device treatment. Circ J. 2015;79:1994–9.
Sayer G, Sarswat N, Kim GH, et al. The hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices. J Card Fail. 2017;23:545–51.
Truby LK, Garan AR, Givens RC, et al. Aortic insufficiency during contemporary left ventricular assist device support: analysis of the INTERMACS registry. JACC Heart Fail. 2018;6:951–60.
Comments (0)